Form 8-K - Current report:
SEC Accession No. 0001193125-25-135341
Filing Date
2025-06-05
Accepted
2025-06-05 08:22:07
Documents
12
Period of Report
2025-06-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d40252d8k.htm   iXBRL 8-K 21538
  Complete submission text file 0001193125-25-135341.txt   134733

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btmd-20250602.xsd EX-101.SCH 2832
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20250602_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20250602_pre.xml EX-101.PRE 11246
14 EXTRACTED XBRL INSTANCE DOCUMENT d40252d8k_htm.xml XML 3634
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 251025077
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)